Which politicians do you trust more to micromanage your health care: federal or state? That’s the false choice presented by two versions of “federalism” intended to divide responsibility for health policy between the national government and the states.

Requirements to test new drugs against older medicines would add a major hurdle to the development and approval of new medicines. Equally important, the proposed mandates are unnecessary.

Cases that will have profound effects on ObamaCare's future are already pending before the Supreme Court. The justices will get these cases right.

The Obama administration envisions accountable care organizations (ACOs) as the drivers of health care innovation, but such innovation has historically come from entrepreneurs in the private sector.

Left ventricular assist devices, or "heart pumps," are proving to be the best available option for patients with advanced heart failure, and the technology has huge potential for improvement.

DDT is still a critical weapon in the battle against malaria and other insect-borne diseases.

Some consumers and businesses might see a little extra cash this summer as a result of the 2010 health care law. The Kaiser Family Foundation recently reported an estimated $1.3 billion in rebates will be delivered from health insurers who spent more than the law allotted on administrative expenses and profits.

Variations in service use across regions are smaller for the private sector than for Medicare, suggesting better management in the private sector.